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Abstract. 
 
After endocytosis cholera toxin is trans-
ported to the endoplasmic reticulum (ER), from where 
its A1 subunit (CTA1) is assumed to be transferred to 
the cytosol by an as-yet unknown mechanism. Here, ex-
port of CTA1 from the ER to the cytosol was investi-
gated in a cell-free assay using either microsomes 
loaded with CTA1 by in vitro translation or reconsti-
 
tuted microsomes containing CTA1 puriﬁed from 
 
V
 
.
 
 
cholerae
 
. Export of CTA1 from the microsomes was 
time- and adenosine triphosphate–dependent and re-
quired lumenal ER proteins. By coimmunoprecipita-
tion CTA1 was shown to be associated during export 
with the Sec61p complex, which mediates import of 
proteins into the ER. Export of CTA1 was inhibited 
when the Sec61p complexes were blocked by nascent 
polypeptides arrested during import, demonstrating 
that the export of CTA1 depended on translocation-
competent Sec61p complexes. Export of CTA1 from 
the reconstituted microsomes indicated the de novo in-
sertion of the toxin into the Sec61p complex from the 
lumenal side. Our results suggest that Sec61p complex–
mediated protein export from the ER is not restricted 
to ER-associated protein degradation but is also used 
by bacterial toxins, enabling their entry into the cytosol 
of the target cell.
Key words: cholera toxin • endoplasmic reticulum • 
Sec61p complex • translocation • endoplasmic reticu-
lum–associated protein degradation
 
Introduction
 
Several bacterial and plant toxins covalently modify cyto-
solic proteins of mammalian cells. To reach their target
 
proteins these toxins have to gain access to the cytosol
of the intoxicated cell. One group of these toxins, exem-
plified by diphtheria toxin, undergoes a conformational
change induced by the acidic pH inside endosomes or lyso-
somes, allowing these toxins to penetrate directly through
the lipid phase of the endosomal–lysosomal membrane
(for review see Olsnes et al., 1988). In contrast to this
group of toxins, the intoxication by cholera toxin,
 
 E
 
.
 
 coli
 
heat labile enterotoxin, 
 
Pseudomonas aeruginosa
 
 exotoxin
A, Shiga toxin, ricin, and modeccin can be prevented by
preincubating the cells with brefeldin A (Yoshida et al.,
1991; Donta et al., 1993; Nambiar et al., 1993; Orlandi et al.,
1993). Brefeldin A inhibits transport between the ER and
the Golgi apparatus. Therefore, this second group of tox-
ins is assumed to be transported from the plasma mem-
brane via the Golgi apparatus to the ER and to cross the
membrane there (for reviews see Pelham et al., 1992;
Hazes and Read, 1997; Lord and Roberts, 1998; Lencer et al.,
1999). Indeed, the appearance in the ER of Shiga toxin
(Sandvig et al., 1992; Johannes et al., 1997) and of cholera
toxin A1 subunit (CTA1)
 
1
 
 (Majoul et al., 1996) has been
demonstrated. For a mutant ricin containing additional
 
N
 
-glycosylation sites at its COOH terminus, it was shown
that it reached the cytosol after being glycosylated in the
ER (Rapak et al., 1997). However, direct experimental ev-
idence is lacking that would indicate whether the transfer
to the cytosol takes place from the ER. It is also unknown
whether this transfer is accomplished by a change in the
conformation of the toxins and direct penetration through
the lipid phase of the membrane, or whether the transloca-
tion apparatus of the ER is used by the toxins to achieve
their transfer across the membrane.
The latter speculation is attractive in light of recent find-
ings on the degradation of misfolded secretory and mem-
brane proteins, a process called ER-associated protein
degradation (for review see Brodsky and McCracken,
1999; Plemper and Wolf, 1999). Degradation by cytosoli-
cally localized proteasomes was first demonstrated for the
misfolded membrane protein cystic fibrosis transmem-
brane conductance regulator (Jensen et al., 1995; Ward et al.,
1995), and for the misfolded secretory protein 
 
a
 
1-anti-
trypsin (
 
a
 
1-AT) Z in mammalian cells (Qu et al., 1996), as
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well as for mutant forms of carboxypeptidase Y (CPY*)
(Hiller et al., 1996) and for unglycosylated pro–
 
a
 
-factor
(Werner et al., 1996) in yeast. Degradation of these pro-
teins by proteasomes implied their transfer from the ER to
the cytosol. Recently, it was shown that degradation inter-
mediates of the major histocompatibility complex class
I heavy chain (Wiertz et al., 1996) and of cystic fibro-
sis transmembrane conductance regulator (Bebök et al.,
1998) were associated with the Sec61p complex, suggesting
that the Sec61p complex might be involved in the transfer
of degradation substrates from the ER to proteasomes.
The function of the Sec61p complex in delivering mis-
folded pro–
 
a
 
-factor (Pilon et al., 1997) and CPY* (Plem-
per et al., 1997) to proteasomes was implicated by genetic
studies in yeast. It is as yet unknown whether the mis-
folded proteins had completely left the Sec61p complex
before their export was initiated and therefore required
the de novo insertion into the channel from the lumenal
side. However, de novo insertion is the prerequisite for the
Sec61p complex–mediated export of proteins such as
bacterial toxins that did not enter the ER via the Sec61p
complex.
In contrast to its possible function in protein export, the
function of the Sec61p complex in the import of proteins
into the ER is well established (for reviews see Rapoport
et al., 1996; Johnson, 1997). Proteins enter the ER through
a channel that provides an aqueous environment for the
translocating polypeptide chain (Crowley et al., 1994). The
Sec61p complex was shown by EM to form a tunnel
through the lipid bilayer (Hanein et al., 1996), which is
in alignment with the channel formed by the large riboso-
mal subunit (Beckmann et al., 1997), suggesting that the
Sec61p complex is the protein-conducting channel. In-
deed, translocation was reconstituted in proteoliposomes
containing only the Sec61p complex, the signal recognition
particle receptor, and the translocating chain-associating
membrane protein (Görlich and Rapoport, 1993). Under
certain conditions the Sec61p complex alone was sufficient
for translocation of proteins across the ER membrane
(Jungnickel and Rapoport, 1995).
Based on the studies on the ER-associated protein deg-
radation, protein translocation by the Sec61p complex
seems to be possible in both directions, i.e., into and out of
the ER. Therefore, we asked the question whether CTA1
utilizes the Sec61p complex to cross the membrane of the
ER and enter the cytosol of the target cell. For this pur-
pose we reconstituted the transfer of CTA1 from the
lumen of the ER to the cytosol in a cell-free system us-
ing ER-derived, translocation-competent microsomes. We
show that the export of CTA1 from the microsomes is in-
deed mediated by the Sec61p complex.
 
Materials and Methods
 
Plasmids and In Vitro Transcription
 
For the construction of plasmid pSPCTA1 coding for the complete CTA1
(amino acids 1–212 of cholera toxin A subunit; sequence data available
from EMBL/GenBank/DDBJ/Swissprot under accession no. P01555)
(Mekalanos et al., 1983) the region of pRIT10841 (no. 39053; ATCC) cor-
responding to nucleotides 501–1151 of the cholera toxin gene (sequence
data available from EMBL/GenBank/DDBJ under accession no. X00171)
(Mekalanos et al., 1983) was amplified by PCR using a 3
 
9
 
-primer, inserting
 
a stop codon after amino acid 212, and subcloned into the plasmid vector
pSVSport1 (Life Technologies). For the construction of CTA1Ins, the
cDNA coding for B5Ser-proinsulin (Schmitz et al., 1995), except for the sig-
nal peptide and the first two amino acids of the mature protein, was fused in
frame to the last codon of CTA1. The constructs were controlled by DNA
sequencing (SequiServe). For the generation of CTA1
 
D
 
137 (encoding the
first 75 amino acids of CTA1) or of DHFR
 
D
 
112 (encoding the first 75
amino acids of mouse dihydrofolate reductase [DHFR]), the corresponding
sequence of pSPCTA1 or of pGEM4-DHFR (gift of Dr. T. Langer, Lud-
wig-Maximilians-Universität, Munich, Germany) including the SP6 pro-
moter was amplified by PCR and used as a template for in vitro transcription.
The 3
 
9
 
-primer used for the generation of CTA1
 
D
 
137 coded for an addi-
tional methionine. Therefore, both CTA1
 
D
 
137 and DHFR
 
D
 
112 contained
four methionine residues allowing the same level of labeling. The cDNA
coding for 
 
a
 
1-AT was obtained from ATCC (no. 61594) and subcloned into
the vector pSVSport1. All templates were transcribed with the AmpliScribe
SP6 High Yield Transcription Kit (Epicentre Technologies).
 
Export Assay
 
High salt–washed microsomes were prepared from porcine pancreas
(Walter and Blobel, 1983). The purity and integrity of the preparation
was verified by determining the absorbance at 260 and 280 nm (OD
 
260
 
/
OD
 
280
 
 
 
. 
 
1.8) and by electron microscope examination (see below). The
microsomes were loaded by cotranslational translocation of in vitro trans-
lated CTA1. The in vitro translation reaction contained 50% reticulocyte
lysate (Promega), 0.3 
 
m
 
Ci/
 
m
 
l [
 
35
 
S]methionine, 0.05 
 
m
 
g/
 
m
 
l mRNA, 0.4 U/
 
m
 
l
RNasin, and 0.1 eq/
 
m
 
l microsomes (for definition of eq, see Walter and
Blobel, 1983). Translation was performed for 10 min at 30
 
8
 
C and stopped
by the addition of puromycin (2 mM final concentration) for 5 min. The
microsomes were separated from the lysate by centrifugation (9,000 
 
g
 
, 10
min, 4
 
8
 
C), resuspended in cold PBS, and divided into aliquots (each corre-
sponding to a 10-
 
m
 
l translation reaction). The export reaction was started
by the addition of twofold concentrated export buffer plus ATP (4 mM
MgCl
 
2
 
, 2 mM ATP, 20 mM creatine phosphate, 400 
 
m
 
g/ml creatine kinase
in PBS, pH 7.5) or twofold concentrated export buffer minus ATP (4 mM
MgCl
 
2
 
, 50 mM glucose, 60 U/ml hexokinase in PBS, pH 7.5), and incu-
bated at 30
 
8
 
C. At the end of the export period, the microsomes were reiso-
lated by centrifugation. The microsomal pellet and the supernatant were
analyzed by SDS-PAGE (Schägger and von Jagow, 1987) using a 12%
separating gel and autoradiography. To analyze export in the presence of
cytosol, microsomes loaded with CTA1 were resuspended in 50% reticu-
locyte lysate in export buffer plus ATP. At the end of the export period,
the microsomes were separated by centrifugation, and CTA1 present in
the supernatant was isolated by immunoprecipitation with anti–cholera
toxin antiserum (Guildhay).
For quantitative analysis, the gels were exposed on a phosphor storage
imager (Fuji BAS1000). For each time point, the fraction of CTA1 found
in the supernatant (fs) was calculated as percentage of total CTA1 present
in the pellet and the supernatant. The export at a given time point [e
 
t(x)
 
]
was determined by subtracting fs at 0 min export from fs at the given time
(
 
e
 
t
 
(
 
x
 
)
 
 
 
5
 
 
 
fs
 
t
 
(
 
x
 
)
 
 
 
2
 
 
 
fs
 
t
 
(0)
 
).
 
Protease Protection Assays
 
Microsomes were loaded with CTA1 and isolated at the end of translation
by centrifugation. The microsomes were resuspended in PBS containing
the indicated concentration of trypsin, and where indicated, 1% Triton X
(TX)-100. After incubation for 30 min on ice, trypsin activity was stopped
by the addition of phenylmethylsulfonylfluoride to 1 mM and the products
were analyzed by SDS-PAGE and autoradiography.
 
Protease Resistance Assay
 
After translation, the microsomes were isolated by centrifugation. One al-
iquot was boiled for 5 min in 0.5% SDS, the other aliquot was kept on ice.
Both aliquots were diluted with 5 vol of PBS containing 1% TX-100,
treated with the indicated concentrations of trypsin or proteinase K, re-
spectively, for 30 min on ice and further processed as described above.
 
Coimmunoprecipitation of CTA1 with the
Sec61p Complex
 
Translation of CTA1 (15 min) or 
 
a
 
1-AT (30 min) was stopped by the ad-
dition of 2 mM puromycin for 5 min, and the microsomes were isolated by 
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centrifugation, resuspended in export buffer minus ATP, and chased for
up to 1 h at 30
 
8
 
C. At the end of the chase, 5 vol of 0.5 M potassium acetate,
pH 7.5, 5 mM MgCl
 
2
 
, 0.2 mM GTP, 1 mM puromycin were added and the
microsomes were incubated for further 15 min at 30
 
8
 
C. The samples were
adjusted to 0.75% deoxyBigCHAP (Calbiochem) and incubated for 20
min on ice. After clearing the lysate (18,000 
 
g
 
, 15 min, 4
 
8
 
C) BSA was
added to 0.2%. CTA1, 
 
a
 
1-AT, or the Sec61p complex were immunopre-
cipitated for 3 h at 4
 
8
 
C using goat anti–cholera toxin antiserum, rabbit
anti–
 
a
 
1-AT antiserum (Calbiochem), or rabbit anti-Sec61
 
b
 
 antiserum
(High et al., 1993), which had been bound to protein G–agarose. Controls
were treated with protein G–agarose only. Washings were done with 0.5 M
potassium acetate, pH 7.5, 0.25% deoxyBigCHAP. The samples were
analyzed by SDS-PAGE. For 
 
a
 
1-AT, a 10% separating gel was used
(Laemmli, 1970). Immunoprecipitated bands were quantified using a
phosphor storage imager.
 
Isolation of Ribosome Nascent Chain Complexes
 
CTA1
 
D
 
137-mRNA or DHFR
 
D
 
112-mRNA was translated for 10 min in a
reticulocyte lysate. Translation was stopped by cycloheximide (0.3 mM)
and the reaction diluted with the same volume of 1 M potassium acetate,
50 mM Tris-Cl, pH 7.5, 250 mM sucrose, 5 mM magnesium acetate. Ribo-
some nascent chain complexes (RNCs) were isolated by centrifugation at
40,000 
 
g
 
 for 1 h and resuspended in 2
 
3
 
 binding buffer (1 mM GTP, 8 
 
m
 
g/
ml aprotinin, 20 
 
m
 
M E-64 in PBS).
 
Blocking Sec61p Complexes by RNCs
 
For blocking the Sec61p complexes with isolated RNCs, the microsomes
(0.025 eq/
 
m
 
l) were loaded with CTA1, reisolated, and resuspended in ex-
port buffer plus ATP. One half of the microsomes was incubated for 10
min at 30
 
8
 
C with a saturating amount of CTA1
 
D
 
137, the other half with
DHFR
 
D
 
112. The microsomes were used for an export reaction in the
presence of ATP as described above with the only exception being that
RNase A was added to 300 
 
m
 
g/ml for 5 min at the end of the export period
and before centrifugation.
The amount of CTA1
 
D
 
137 necessary to saturate the available Sec61p
complexes was determined by incubating in binding buffer as above 0.25 eq
microsomes with increasing amounts of CTA1
 
D
 
137. After binding, 1 vol
of 1 M potassium acetate, 4 mM MgCl
 
2
 
, 4 mM DTT, 80 mM Hepes, pH
7.5, was added and the microsomes were incubated for 15 min on ice. Af-
ter centrifugation, the microsomal pellet and the supernatant were ana-
lyzed by SDS-PAGE and autoradiography. CTA1
 
D
 
137 isolated from a 60-
 
m
 
l translation reaction was sufficient for saturation. In the competition
experiments RNCs isolated from 100 
 
m
 
l translation reactions were used.
 
Preparation of Lumenal Proteins
 
For the preparation of lumenal microsomal proteins, high salt EDTA-
washed microsomes were suspended at 1 eq/
 
m
 
l in 25 mM Tris-Cl, pH 7.5,
250 mM sucrose, 23 mM 
 
N
 
-octylglucoside (Calbiochem), and incubated
for 30 min on ice. After centrifugation in a Ti55.2 rotor (55,000 rpm, 1 h),
the supernatant containing the lumenal proteins was precipitated by am-
monium sulfate (90% saturation). The precipitate was desalted using
EconoPac 10 DG columns (Bio-Rad) equilibrated in 25 mM Tris-Cl, pH
7.5, 250 mM sucrose. To remove the detergent, each milliliter of extract
was transferred to 200 mg Bio-Beads SM-2 (Bio-Rad) and incubated for
2 h at 4
 
8
 
C with one change of Bio-Beads. The fluid phase is referred to as
lumenal proteins.
 
Extraction and Resubstitution of Microsomes
 
For the resubstitution of lumenal proteins and the reconstitution of
CTA1-containing microsomes, the method of Görlich and Rapoport to
prepare proteoliposomes from microsomal membrane extracts was
adapted (Görlich and Rapoport, 1993). Microsomes (1 eq/
 
m
 
l) were perme-
abilized in 50 mM Hepes-KOH, pH 7.8, 350 mM potassium acetate, 12 mM
MgCl
 
2
 
, 5 mM 
 
b
 
-mercaptoethanol, 15% glycerol, 0.24% deoxyBigCHAP
for 30 min on ice. 100-
 
m
 
l portions were added to 40 mg Bio-Beads SM-2
and incubated for 3–4 h on a rotating device at 4
 
8
 
C. The fluid phase was
separated and diluted with 10 vol of cold Tris-buffered saline, pH 7.5. The
resealed microsomes were collected by centrifugation (18,300 
 
g
 
, 15 min,
4
 
8
 
C) (extracted microsomes). For resubstitution with lumenal proteins,
100 eq extracted microsomes were resuspended in 100 
 
m
 
l buffer (25 mM
Tris-Cl, pH 7.5, 250 mM sucrose, 0.24% deoxyBigCHAP) containing 2 eq/
 
m
 
l
lumenal proteins. For reconstituting CTA1-containing microsomes, ex-
tracted microsomes were incubated with 0.2 mg/ml CTA (Calbiochem)
alone or with 0.2 mg/ml CTA and 2 eq/
 
m
 
l lumenal proteins. After a 30-min
incubation at 4
 
8
 
C, the detergent was removed and the microsomes col-
lected as above. Mock-treated microsomes were treated identically to ex-
tracted microsomes but the detergent was omitted. The microsomes were
resuspended at 1 eq/
 
m
 
l in 25 mM Tris-Cl, pH 7.5, 250 mM sucrose. If not
stated otherwise, 1 eq was used per 10-
 
m
 
l translation reaction and 1.6 eq
for the corresponding nonradioactive assays.
For the analysis of the extraction-resubstitution, identical amounts of
the microsomes were separated by SDS-PAGE (Laemmli, 1970) and
heavy chain binding protein (BiP) was detected by immunoblot using a
goat anti-BiP antiserum (Santa Cruz Biotechnology).
 
EM of Microsomal Preparations
 
Microsomes were fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer,
pH 7.6, postfixed in 1% OsO
 
4
 
 in H
 
2
 
O, stained en bloc with 2% uranyl ace-
tate in H
 
2
 
O, dehydrated, and embedded in epon. Sections were mounted
on formvar-coated grids and viewed in a Philips electron microscope
CM120. Care was taken to search in all parts of the microsomal pellets for
possible contaminations. Only fractions with highest microsomal purity
were used for the experiments (data not shown).
 
Results
 
The aim of this study was to elucidate the mode of export
of CTA1 from the lumen of the ER to the cytosol. For this
purpose we established a cell-free export system using
translocation-competent microsomes as an in vitro substi-
tute for the ER. The microsomes were either loaded with
in vitro synthesized CTA1 by cotranslational import of the
protein, or reconstituted with CTA1 purified from 
 
V
 
.
 
 chol-
erae
 
, and the export of CTA1 from the microsomes was
analyzed.
 
Import and Folding of CTA1 in Microsomes
 
CTA1 was in vitro synthesized in a reticulocyte lysate and
cotranslationally imported into the lumen of microsomes.
Upon import into the microsomes, the signal peptide of
the precursor of CTA1 was removed, resulting in a higher
electrophoretic mobility of CTA1 as compared with pre-
CTA1 (Fig. 1, lanes 1 and 2). When the microsomes were
separated from the reticulocyte lysate by centrifugation,
CTA1 was found in the microsomal pellet (Fig. 1, lane 3).
To demonstrate that CTA1 was not simply attached to the
outside of the microsomal membranes, the microsomes
were treated with trypsin after translation. CTA1 was
completely degraded in the presence of detergent but pro-
tected from degradation in the absence of detergent, dem-
onstrating its complete transfer across the microsomal
membrane (Fig. 1, lanes 3–5). To use glycosylation as addi-
tional evidence for import of CTA1 into the microsomes,
a mutant proinsulin containing an 
 
N
 
-glycosylation site
(Schmitz et al., 1995) was added to the COOH terminus of
CTA1, which itself is not glycosylated. The electrophoretic
mobility of this fusion protein (CTA1Ins) was increased
when a competitive inhibitor of the lumenally active oligosac-
charyltransferase was added (Fig. 1, lanes 9 and 10), indicat-
ing that it was glycosylated after import into the microsomes.
Similar to CTA1, CTA1Ins was protected from trypsin added
to the outside of the microsomes (Fig. 1, lanes 6–8), again
demonstrating its complete import into the microsomes.
After import into the microsomes, CTA1 might remain
largely unfolded or misfolded or it might fold into a com-
pact conformation. To discriminate between these possi- 
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bilities CTA1 was treated with proteases under nondena-
turing or denaturing conditions. In the first case, the
microsomes were lysed with TX-100, whereas in the latter
case the microsomes were first boiled in SDS and then the
SDS was quenched by the addition of TX-100. Digestion
of these samples with increasing concentrations of trypsin
showed that CTA1 lost its resistance against proteolysis
upon denaturation (Fig. 2). The same result was obtained
using the more promiscuous protease proteinase K. The
finding that CTA1 became more sensitive to proteolysis
upon denaturation argued against the possibility that the
in vitro synthesized and imported CTA1 remained un-
folded or was grossly misfolded, but indicated that it had
folded into a compact conformation inside the micro-
somes. This assumption is supported by the finding that
treatment of CTA1Ins with a low concentration of trypsin
resulted in the degradation of the proinsulin moiety,
whereas the CTA1 moiety remained stable (Fig. 1, lane 8).
In contrast to CTA1, the proinsulin moiety, which con-
tains three disulfide bonds, cannot fold correctly in the re-
ducing environment of the in vitro translation system.
Thus, by the criteria of signal peptide cleavage, glycosyla-
tion, protease protection, and protease resistance, CTA1
was completely imported into the microsomes where it
folded into a compact conformation.
 
Export of CTA1 from Microsomes
 
The export assay is composed of two steps: first, the load-
ing of the microsomes with CTA1 as described above; and
second, the actual export from the lumen of the mi-
crosomes into the surrounding buffer. After the termina-
tion of translation by the addition of puromycin, the mi-
crosomes were separated from the reticulocyte lysate by
centrifugation, resuspended in buffer with or without
ATP, and divided into aliquots, which were incubated for
increasing chase periods. At the end of the chase period
the microsomes were separated from the buffer by centrif-
ugation and both fractions analyzed by SDS-PAGE and
autoradiography. Whereas in the absence of ATP CTA1
was barely detectable in the buffer, a time-dependent in-
crease of CTA1 in the buffer was found in the presence of
an ATP regenerating system (Fig. 3 a). The exported
CTA1 had the same electrophoretic mobility as the CTA1
present in the microsomes, indicating that its signal pep-
tide had been cleaved after import into and before export
from the microsomes. In addition, the identical molecular
weight of microsomal and exported CTA1 indicated that
exported CTA1 was not ubiquitinated. In agreement with
this observation, no ubiquitinated CTA1 was found by im-
munoblot analysis using an antiubiquitin antibody (data
not shown).
To calculate export rates, the fraction of CTA1 present
in the buffer was determined for each time point. From
this value the amount of CTA1 found in the buffer at 0
min export, which was in average 5.3% (
 
6 
 
3.4% SD;
 
 n 
 
5
 
21), was subtracted (Fig. 3 b). The mean export rate of re-
actions performed in the presence of ATP was 17.8%/h (
 
6
 
5.8% SD), whereas export in the absence of ATP was
1.9%/h (
 
6 
 
0.8% SD). The export was not significantly
changed by the addition of cytosol (22.5%/h 
 
6 
 
5.1% SD).
The kinetics of export differed between different microso-
mal preparations in that export was more pronounced dur-
ing the first hour in some preparations and during the sec-
ond hour in other preparations. The reason for this
difference is not yet clear.
To exclude the possibility that export of CTA1 from the
microsomes occurred because the in vitro synthesized
CTA1 had not been completely released from the lumenal
side of the Sec61p complex after its import, a different ap-
proach to load the microsomes with CTA1 was used. For
this purpose, microsomes were reconstituted with CTA1,
which had been isolated from 
 
V
 
.
 
 cholerae
 
. The loss of lu-
menal ER proteins during the reconstitution was pre-
vented by adding concentrated lumenal ER proteins to the
reconstitution buffer. The reconstituted CTA1-containing
microsomes were used for an export assay as described
Figure 1. Import of CTA1 into microsomes. CTA1 (lanes 1–5)
and CTA1Ins (lanes 6–10) were translated in a reticulocyte ly-
sate. (Lanes 1 and 2) After translation in the absence or presence
of microsomes, CTA1 and its precursor (preCTA1) were immu-
noprecipitated. (Lanes 3–8) After translation, the microsomes
were isolated by centrifugation and treated with trypsin or
trypsin and TX-100. (Lanes 9 and 10) Glycosylation of CTA1Ins
was inhibited by the addition of the tripeptide N-acetyl-NLT-
NH2 (100 mM). The proteins were analyzed by SDS-PAGE and
autoradiography.
Figure 2. Folding of CTA1 inside the microsomes. CTA1 was
translated for 10 min and the microsomes were isolated by cen-
trifugation. One half was boiled for 5 min in 0.5% SDS, the other
half was kept on ice. Both samples were diluted with 5 vol PBS
containing 1% TX-100, divided into aliquots, incubated for 30
min on ice with the indicated concentrations of trypsin (upper
panel) or proteinase K (lower panel), and analyzed by SDS-
PAGE and autoradiography. 
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above. CTA1 was detected by immunoblot using an anti–
cholera toxin antiserum. As with the biosynthetically
loaded microsomes, CTA1 was exported from the recon-
stituted microsomes in an ATP-dependent manner (Fig. 4
a). To demonstrate that the reconstituted microsomes con-
tained CTA1 in their lumen and not only attached to the
outside of the membrane, a protease protection analysis
was performed (Fig. 4 b). CTA1, which was degraded in
the presence of detergent, was protected from degrada-
tion in the absence of detergent. The finding of export of
CTA1 from reconstituted microsomes demonstrated that
export of CTA1 did not require the persistent interaction
of CTA1 with the translocon after import. As folded, en-
zymatically active CTA1 was used for the reconstitution of
the microsomes. This finding also argued against the possi-
bility that the in vitro translated and imported CTA1 was
exported, because it could not fold correctly and thus sim-
ply represented a misfolded protein.
For the reconstitution of the CTA1-containing mi-
crosomes, high salt–washed microsomes, lumenal ER pro-
teins prepared from high salt/EDTA–washed microsomes,
and CTA1 purified from 
 
V
 
.
 
 cholerae 
 
were used. No cytosol
was added before or during export. Both export from the
reconstituted microsomes and the observation that export
was not stimulated by the addition of cytosol (see Fig. 3 b)
supported the conclusion that cytosolic proteins were not
required for the export of CTA1 from microsomes.
 
Export of CTA1 Is Mediated by the Sec61p Complex
 
To analyze whether export of CTA1 was mediated by the
Sec61p complex, the physical interaction of CTA1 with the
Sec61p complex was examined. The import of the in vitro
translated CTA1 was stopped by the addition of puromy-
cin, which induces the release of unfinished nascent chains
from the ribosome and from the Sec61p complex (Görlich
et al., 1992). The microsomes were reisolated and chased
in export buffer without ATP to stabilize the export inter-
mediate which was assumed to interact with the Sec61p
complex. At the end of the chase, the microsomes were
stripped of remaining ribosomes by incubation in high salt/
puromycin buffer and lysed with deoxyBigCHAP, which
leaves the Sec61p complex intact (Görlich et al., 1992).
The Sec61p complex was immunoprecipitated with an
anti-Sec61
 
b
 
 antiserum under high salt conditions (Fig. 5).
CTA1 was coimmunoprecipitated with the Sec61p com-
plex, indicating their physical interaction. The nonex-
ported secretory protein 
 
a
 
1-AT was not coimmunoprecip-
Figure 3. Export of CTA1 from microsomes. (a) After translation (10 min) of CTA1 in a single reaction, the microsomes were reiso-
lated by centrifugation, resuspended in PBS, and divided into aliquots. The export reaction was started by the addition of export buffer
with or without ATP. At the end of the chase period the microsomes were reisolated by centrifugation. The presence of CTA1 in the
microsomal pellet and the supernatant was analyzed by SDS-PAGE and autoradiography. (b) Statistical analysis of export reactions
performed for 1 h without ATP (n 5 5), with ATP (n 5 13), or with ATP and cytosol (n 5 5). For the calculation of export rates, the
fraction of CTA1 found in the supernatant at 0 min chase was subtracted. Bars represent SD.
Figure 4. Export from reconstituted microsomes. (a) Mi-
crosomes reconstituted with CTA1 and lumenal ER proteins (see
Materials and Methods) were resuspended in export buffer with
or without ATP and used for an export reaction as described in
Fig. 3 a. CTA1 was detected by immunoblot using an anti–chol-
era toxin antiserum. The export rates per hour were ,1% in the
absence of ATP and 9% in the presence of ATP, respectively. 10 ng
of the CTA1 used for the reconstitution was loaded as a standard
(st). (b) Reconstituted microsomes were treated with 100 mg/ml
trypsin in the absence or presence of TX-100. CTA1 was detected
by immunoblot.The Journal of Cell Biology, Volume 148, 2000 1208
itated with the Sec61p complex, indicating the specificity
of the interaction between CTA1 and the Sec61p complex.
In three independent experiments, the fraction of coim-
munoprecipitated CTA1 consistently increased during the
chase period by a factor between 1.5 and 2, indicating that
CTA1 had left the Sec61p complex after import and reas-
sociated with it during the export. It has been suggested
that Sec61b may, under certain conditions, exist in the ER
membrane as an individual protein, i.e., not integrated
into the Sec61p complex (Kalies et al., 1998). Therefore, it
cannot be entirely excluded that CTA1 was associated
with this fraction of Sec61b.
To establish that the Sec61p complex was functionally
necessary for the export of CTA1, a block of the Sec61p
complex was used. It is well established that the nascent
chain is released and the ribosome dissociates from the
Sec61p complex when the stop codon of a translated
mRNA molecule is reached. This termination reaction can
be prevented by the translation of mRNA lacking the stop
codon, resulting in a tight complex between the ribosome,
the Sec61p complex, and the truncated nascent chain that
is arrested in transit through the Sec61p complex.
Microsomes were loaded with CTA1 by in vitro transla-
tion. The reisolated microsomes were then incubated with
truncated nascent chains that had been isolated as RNCs
from a separate translation reaction. The RNCs were gen-
erated by translation of CTA1D137, which corresponds to
the first 75 amino acids of CTA1, or of DHFRD112, which
corresponds to the first 75 amino acid of DHFR. As
Figure 5. Association of CTA1 with the Sec61p complex during
export. Translation of CTA1 or a1-AT was terminated by the ad-
dition of puromycin and the microsomes were reisolated and re-
suspended in export buffer minus ATP. After a chase for the in-
dicated time, the microsomes were incubated in puromycin/high
salt buffer and lysed with 0.75% deoxyBigCHAP. CTA1, a1-AT,
and the Sec61p complex were immunoprecipitated with anti–
cholera toxin antiserum (CT), anti–a1-AT antiserum, or anti-
Sec61b antiserum, respectively. For the immunoprecipitation
with the anti-Sec61b antiserum and for the controls without anti-
body (2ab) the threefold amount of microsomes was used as
compared with the anti–cholera toxin and anti–a1-AT immuno-
precipitations. During the chase, the fraction of CTA1 coimmu-
noprecipitated with the Sec61p complex increased from 2 to 4%. Figure 6. Sec61p complex–mediated export of CTA1. (a) Mi-
crosomes were loaded with CTA1 by in vitro translation, isolated
by centrifugation, and resuspended in export buffer containing
ATP. One half of the microsomes was incubated for 10 min at
308C with saturating amounts (corresponding to a 100-ml transla-
tion reaction; see below) of CTA1D137, the other half with
DHFRD112, which did not contain a signal peptide and was used
as a control. After binding of the RNCs, the microsomes were
used for an export reaction as described in Fig. 3 a. CTA1,
CTAD137, and DHFRD112 were detected by autoradiography.
Export rates per hour were ,1% in the presence of CTA1D137
and 11% in the presence of DHFRD112, respectively. (b) Mi-
crosomes were incubated with increasing amounts of CTA1D137.
After binding, the microsomes were high salt–washed to remove
unspecifically bound RNCs. The reactions were separated by
centrifugation in a pellet fraction containing the Sec61p com-
plex–bound RNCs and a supernatant fraction containing the un-
bound RNCs. The amount of CTA1D137 isolated from a 60-ml
translation reaction was sufficient to saturate the microsomes. (c)
Microsomes reconstituted with purified CTA1 and lumenal ER
proteins were incubated with RNCs and used for an export reac-
tion exactly as described in a. CTA1 and CTA1D137 were de-
tected by immunoblot using an anti–cholera toxin antiserum.
Due to the immunodetection DHFRD112 is not visible. Export
rates per hour were ,1% in the presence of CTA1D137 and 16%
in the presence of DHFRD112, respectively.Schmitz et al. Export of Cholera Toxin from Microsomes 1209
DHFR does not contain a signal peptide and is not im-
ported into microsomes, it was used as a control to demon-
strate that only signal peptide containing RNCs inhibit ex-
port of CTA1. When export of CTA1 was performed in
the presence of saturating amounts of CTA1D137, the ex-
port of CTA1 was completely inhibited. In contrast, ex-
port occurred unhindered when DHFRD112 was used for
competition (Fig. 6 a). In this type of experiment the
export was consistently more pronounced in the second
hour of chase. The saturation of all Sec61p complexes
with CTA1D137 was verified by determining the maximal
amount of RNCs bound to the microsomes in a high salt–
resistant manner, indicating their insertion into the Sec61p
complex (Fig. 6 b). RNCs isolated from a 60-ml translation
reaction were sufficient to saturate all Sec61p complexes
available in 0.25 eq microsomes. In the competition exper-
iments, RNCs isolated from 100-ml translation reactions
were used.
To demonstrate that the export of CTA1 was also inhib-
ited by CTA1D137 under conditions where persistent in-
teraction of CTA1 with the Sec61p complex after import
could be excluded, microsomes reconstituted with puri-
fied CTA1 and lumenal ER proteins were used. In addi-
tion, under these experimental conditions export of CTA1
was inhibited by the addition of CTA1D137 but not by
DHFRD112 (Fig. 6 c).
The competition data demonstrated that the export of
CTA1 was inhibited by functionally blocking the Sec61p
complex. Together with the coimmunoprecipitation data
demonstrating association of CTA1 with the Sec61p com-
plex during export, these results indicated that the Sec61p
complex mediated the export of CTA1 across the microso-
mal membrane.
Export of CTA1 Requires Lumenal ER Proteins
To test whether in addition to the Sec61p complex lume-
nal ER proteins were required for export of CTA1, mi-
crosomes were depleted of their lumenal proteins by de-
tergent extraction (Fig. 7 a). In contrast to mock-treated
microsomes, the extracted microsomes that were still able
to import CTA1 showed no export of CTA1. The export
of CTA1 was recovered after resubstituting the extracted
microsomes with lumenal ER proteins. The efficiency of
the depletion and resubstitution was verified by immuno-
detection of the ER-resident chaperone BiP (Fig. 7 b).
The inability of the extracted microsomes to export
CTA1 could be caused indirectly by their inability to sup-
port the folding of the newly imported CTA1, which due
to aggregation could be unavailable for export. To exclude
this possibility, microsomes were reconstituted with puri-
fied, folded, and enzymatically active CTA1 either in the
presence or absence of lumenal ER proteins. Also, under
these conditions export occurred only in the presence of
lumenal ER proteins (Fig. 7 c). The finding that depletion
of lumenal ER proteins resulted in a reversible export in-
hibition demonstrated that lumenal ER proteins were re-
quired for export of CTA1.
Figure 7. Dependence of
CTA1 export on lumenal ER
proteins. Microsomes were
depleted of their lumenal
proteins by extraction with
deoxyBigCHAP or were, af-
ter extraction, resubstituted
with lumenal ER proteins.
(a) Mock-treated, extracted,
or resubstituted microsomes
were loaded with CTA1 by in
vitro translation. Export of
CTA1 from the different mi-
crosomes was analyzed as de-
scribed in Fig. 3 a. The export
rates per hour were 10, 0, and
11% for the mock-treated,
extracted, and resubstituted
microsomes, respectively. (b)
The efficiency of the extrac-
tion and resubstitution was
verified by the immmunode-
tection of BiP in equal
amounts of mock-treated, ex-
tracted, and resubstituted mi-
crosomes using an anti-BiP
antiserum. (c) Microsomes
were reconstituted with
CTA1 either in the absence
(reconstituted 2 lumenal proteins) or presence (reconstituted 1 lumenal proteins) of lumenal ER proteins. Export of CTA1 was ana-
lyzed as described in Fig. 3 a, with the exception that CTA1 was detected by immunoblot. The export rates per hour were 0 and 8% in
the absence or presence of lumenal proteins, respectively.The Journal of Cell Biology, Volume 148, 2000 1210
Discussion
In this study we show that the bacterial toxin CTA1 is
transferred by the Sec61p complex across the ER mem-
brane. Our findings indicate the existence of export mech-
anisms from the ER to the cytosol independently of pro-
teasomal degradation. As yet, export from the ER to the
cytosol has only been described for proteins destined for
ER-associated protein degradation. Therefore, our results
have implications not only on our current understanding
of CTA1 entry into the target cell but also on a more gen-
eral model of protein translocation across the ER mem-
brane.
Translocation of CTA1 from the ER to the Cytosol
Cholera toxin has been shown to bind to ganglioside GM1,
to be endocytosed via noncoated vesicles (Tran et al.,
1987; Orlandi and Fishman, 1998), and transported to the
Golgi complex where the A and B subunits disassemble
(Bastiaens et al., 1996). Whereas the B subunit remains in
the Golgi complex, the A subunit can reach the ER (Ma-
joul et al., 1996) via coatomer I-coated vesicles (Majoul et al.,
1998), where the disulfide bond between the A1 and A2
subunits is reduced (Majoul et al., 1997; Orlandi, 1997). In
spite of intense research on this intriguing sequence of
events, it is as yet unknown whether this pathway is a pre-
requisite for the translocation of CTA1 to the cytosol or
only a by-product of its internalization. Indeed, earlier re-
ports exist on the B subunit–mediated insertion of CTA1
into liposomes (Tomasi and Montecucco, 1981; Ribi et al.,
1988) and into the membrane of Newcastle disease virus
(Wisnieski and Bramhall, 1981). These reports suggested
that translocation of CTA1 might be independent of pro-
teins of the target cell but be mediated by a conforma-
tional change of the toxin and the consecutive direct pene-
tration through the lipid phase of the membrane. But
these studies were restricted to the insertion of CTA1 into
membranes, and did not address the transfer across the
membranes. In this analysis, the export of CTA1 was
ATP-dependent. As CTA1 is not an ATPase, the ATP de-
pendence indicates that CTA1 interacts directly or indi-
rectly with an ATPase during export. The requirement for
lumenal ER proteins and for the Sec61p complex supports
the view that these proteins of the target cell are essential
for export, and that translocation does not occur through
the lipid phase of the membrane but through the Sec61p
complex–formed channel. The cooperation of these fac-
tors is possible only in the ER and therefore, we conclude
that translocation of CTA1 in vivo also occurs from the
ER. In support of this view, it was shown that brefeldin A
(Donta et al., 1993; Nambiar et al., 1993; Orlandi et al.,
1993) and mutations in the COOH-terminal ER retrieval
signal of the A2 subunit (Lencer et al., 1995) protected
cells from intoxication by cholera toxin, suggesting that
the ER is functionally involved in the intoxication process.
A Common Mechanism for Export of CTA1 and of 
Proteins Destined for Degradation?
Export of CTA1 is inhibited by truncated polypeptides
that are arrested in transit through the Sec61p complex,
demonstrating that the Sec61p complex is essential for the
export of CTA1. As misfolded proteins also appear to be
exported by the Sec61p complex (Wiertz et al., 1996; Pilon
et al., 1997; Plemper et al., 1997; Bebök et al., 1998), a
common export machinery with the Sec61p complex as the
basic element seems to be used. In addition, ER lumenal
proteins are required for export of both CTA1 (this re-
port) and misfolded proteins (Plemper et al., 1997; Brod-
sky et al., 1999). Thus, not only the basic machinery but
also some aspects of the export mechanism may be similar.
One key question concerning this mechanism is whether
the exported misfolded proteins have completely left the
translocon after their import or whether persistent contact
with the translocon is required for export to be initiated.
Posttranslational reinsertion into the translocon has been
inferred from the studies on the degradation of the mem-
brane protein major histocompatibility complex class I
heavy chain, which seemed to be folded before export
from the ER (Wiertz et al., 1996), and of the soluble pro-
tein CPY* (Plemper et al., 1999). However, for both pro-
teins definite proof is lacking that would demonstrate that
they had completely left the translocon before their export
was initiated. Here, Sec61p complex–dependent export of
CTA1 was shown using microsomes reconstituted with pu-
rified CTA1. Under these conditions persistent contact of
the protein with the translocon after its import can be ex-
cluded. Therefore, the export of CTA1 implies that it post-
translationally inserted from the lumenal side into the
translocation channel. More generally, export of CTA1
suggests that insertion from the lumenal side into the
translocon is possible for a soluble protein after cleavage
of the signal peptide, which is the structure recognized by
the Sec61p complex during cotranslational (Jungnickel and
Rapoport, 1995; Mothes et al., 1998) and posttranslational
(Plath et al., 1998) import of polypeptides into the ER.
The observations presented here suggest that the trans-
location of both CTA1 and of proteins destined for degra-
dation is mediated by the Sec61p complex, and may be
based on a similar basic mechanism. However, major dif-
ferences exist that indicate that the translocation mecha-
nisms for both groups of proteins are not identical.
Differences in the Translocation of CTA1 and of 
Degradation Substrates
A tight coupling of export and degradation has been sug-
gested by several studies. The integral membrane proteins
CD4 (Schubert et al., 1998), CD3-d (Yang et al., 1998),
and a synthetic degradation substrate based on the Sec62
protein (Mayer et al., 1998) accumulated in the mem-
brane-bound form when the proteasome was inhibited.
These findings suggested that the catalytic activity of the
proteasome was necessary to trigger by an unknown
mechanism the dislocation of these proteins from the ER
membrane. In contrast, major histocompatibility complex
class I heavy chains were exported when proteasomal ac-
tivity was inhibited (Wiertz et al., 1996), as was pro–a-fac-
tor in the presence of cytosol prepared from yeast mutants
with defective proteasomes (Werner et al., 1996). The cou-
pling of ubiquitination and export was suggested from the
observation that misfolded CPY* accumulated inside the
ER when expressed in yeast mutants defective in the ubiq-
uitination at the ER membrane (Biederer et al., 1997).Schmitz et al. Export of Cholera Toxin from Microsomes 1211
Similarly, a mutant form of ribophorin I accumulated in
the ER when expressed in mammalian cells defective in
the ubiquitin-activating enzyme E1 (de Virgilio et al.,
1998). Although being independent of ubiquitination, ex-
port of pro–a-factor was dependent on the presence of cy-
tosol (McCracken and Brodsky, 1996; Werner et al., 1996).
Here, we show that export of CTA1 requires lumenal
ER proteins but occurs in the absence of cytosol and with-
out apparent ubiquitination. Under the experimental con-
ditions used here, active proteasomes, as identified by
their ability to support the degradation of a mutant form
of a1-AT (Qu et al., 1996), were not detected (data not
shown). Most probably, this lack of active proteasomes is
due to the presence of hemin in the reticulocyte lysate act-
ing as a potent inhibitor of proteasomes (Hough et al.,
1986). Thus, the export of CTA1 seems to be independent
of the cytosolic factors required for the export of proteins
destined for degradation, but seems to rely entirely on fac-
tors residing in the ER lumen and the ER membrane.
The proteasome, ubiquitination, and cytosolic chaper-
ones are discussed to regulate the export of proteins des-
tined for degradation (Brodsky and McCracken, 1999). As
none of these proteins appears to be required for the ex-
port of CTA1, the question arises as to how its export is
regulated. Protein import by the Sec61p complex needs
the cooperation of the complex with other constituents
such as the ribosome during cotranslational import, or the
ER-resident chaperone BiP during posttranslational im-
port in yeast (Sanders et al., 1992; Matlack et al., 1999).
BiP binds to stretches of exposed hydrophobic amino ac-
ids (Flynn et al., 1991; Blond-Elguindi et al., 1993) and ob-
servations indicate that this binding affects the degrada-
tion of secretory proteins in mammalian cells (Knittler and
Haas, 1992; Schmitz et al., 1995). Genetic screens impli-
cated BiP to participate in the export of CPY* (Plemper
et al., 1997) and pro–a-factor (Brodsky et al., 1999) in
yeast. But it is unclear whether BiP provides by its ATPase
activity the driving force for the export of one of these
proteins or is required for the unfolding of the proteins.
BiP might also be involved in the gating of the translocon
for protein export as it was shown to seal nontranslocating
translocons (Hamman et al., 1998). We found that the ex-
port of CTA1 was dependent on ATP and lumenal ER
proteins but independent of cytosolic proteins. Our find-
ings support the view that a basic level of regulation of
protein export from the ER is independent of cytosolic
factors but is achieved by the cooperation of the Sec61p
complex with an ER-resident ATPase.
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